Loading...
Biowaiver monographs for immediate release solid oral dosage forms: prednisolone.
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date
2007-01-01
Research Projects
Organizational Units
Journal Issue
Title
Biowaiver monographs for immediate release solid oral dosage forms: prednisolone.
Translated Title
Published in
Abstract
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing prednisolone are reviewed. Data on its solubility, oral absorption, and permeability are not totally conclusive, but strongly suggest a BCS Class 1 classification. Prednisolone's therapeutic indications and therapeutic index, pharmacokinetics, and the possibility of excipient interactions were also taken into consideration. Available evidence indicates that a biowaiver for IR solid oral dosage forms formulated with the excipients tabulated in this article would be unlikely to expose patients to undue risks.